Possibilities today...Treatments Tomorrow

 

- NORCAL MEDICAL RESEARCH -

NEW CLINICAL STUDIES ENROLLING NOW

 

Why participate?


  • When you particpate in a clinical study you might have access to potentially new treatments not available to the general public.
  • The new treatment being studied may be more effective than the current available therapy and you may be the first to benefit from it.
  • During the study you have access to expert medical care and information from our research team that includes doctors and research coordinators.
  • Participants receive study medications, physical examinations and laboratory tests at no charge and are paid a small stipend for their time and travel.
  • No insurance or info regarding immigration status is required to participate.
  • You continue to receive your usual care from your own physicians with whom we communicate about your results and progress.
  • All participants help others by contributing to medical knowledge.

Hello friend,



As the year unfolds, we continue to enroll patients in new studies and follow patients in our active, ongoing studies. Click here to get acquainted with our physicians and here to meet the rest of our staff.


We are partnering with the top pharmaceutical companies, dedicated healthcare professionals and patient groups. These trials are searching for data to answer important clinical questions.


With these studies, we aim to make significant contributions to the field of endocrinology, improving the lives of individuals worldwide.


We are starting to enroll in a new Diabetic Peripheral Neuropathy Pain study this month. See our February Focus below for details.


Scroll down to read about our other currently enrolling and new studies. Also below, tips about walking and why you may not need to walk 10,000 steps to reap benefits.


In health,


Dr. G

Linda Gaudiani MD FACE FACP

Medical Director


-FEBRUARY FOCUS - NOW ENROLLING-

DIABETIC PERIPHERAL NEUROPATHY PAIN STUDY

Peripheral sensory neuropathy happens when the nerves that are located outside of the brain and spinal cord (peripheral nerves) are damaged. This condition often causes numbness, tingling and pain, usually in the hands and feet. Peripheral neuropathy can result from various conditions, but one of the most common causes is diabetes.


All patients with Type 1 or Type 2 Diabetes should be screened regularly for neuropathy. Effective treatment to reverse underlying nerve damage and relieve pain is currently not available but progression may be slowed. Our study is directed at pain relief in patients who suffer moderate to severe pain from their diabetic peripheral neuropathy (DPN).


Patients will receive a new oral form of a selective inhibitor of AAK1 in addition to their current non-opioid pain meds.


To qualify, patients must be over age 18 with Type 1 or Type 2 Diabetes and moderate to severe DPN.


This study might be right for you if you experience inadequate pain relief from your current treatment.


The goal of this trial is to evaluate the efficacy of the study's medication in reducing pain related to DPN.

OTHER CURRENTLY ENROLLING OR UPCOMING STUDIES

  • We are also recruiting for another Weight Loss Study using a new glucoregulatory hormone similar to GLP-1, a once weekly injectable Amylin analog, for overweight persons without diabetes. The options for treating obesity keep expanding! Call for more information as these studies fill quickly.



  • We will be enrolling patients shortly in a Thyroid Study comparing animal derived thyroid supplements (T3/T4) to synthetic thyroid hormone levothyroxine (T4). Patients will be monitored to keep thyroid levels optimal throughout the study. Click here for more details. See next month's newsletter and this interesting article on the topic.


Contact us at (415) 461-1585 or Info@NorCalMedicalResearch.com with any questions.

TIPS FOR GETTING FIT WITHOUT TRYING TOO HARD

Quick hint... Go for a walk!

We can all reap wonderful phyisical benefits from just going on a walk, and it does not have to be 10,000 steps per day. We are very fortunate to live in an area where there are many options to go for walks and enjoy the outdoors. And this is easily sustainable!


10,000 steps is touted as the magic number that will optimize health and longevity. I come bearing encouraging news: the 10,000-step goal is rooted more in marketing than in science. It started in 1965 in Tokyo, Japan, where a company released an early step counter, calling it manpo-kei- or "10,000 steps meter." The marketing suggested this number of steps would reduce the risk for heart disease.


Today we know that health benefits kick in long before10,000 steps and we should not be intimidated or dissuaded by the 10,000 number.


Just 2,500 steps, or about a mile, are enough to begin reducing your cardiovascular disease risk. The more you walk, the more benefits you reap. You don't need any fancy equipment, so tie on your walking shoes and hit one of the many beautiful trails in the Bay Area, or just get out the door and walk in your neighborhood, and boost your health.


For the benefits associated with walking from 2,500 to 11,500 steps watch the video below.

Contact us at (415) 461-1585 or Info@NorCalMedicalResearch.com with any questions. Please share this newsletter with anyone you think might benefit from receiving it and finding out about our work.


If you or someone you know would like to receive this newsletter IN SPANISH, please reach out to Info@NorCalMedicalResearch.com or call our office.

VISIT OUR WEBSITE

Please forward and share this newsletter with friends and family. Did you receive it from a friend? Click on the link below to subscribe and join our mailing list.


If this email was forwarded to you by someone who thinks you’re a star, subscribe here to get your very own Three or Four Things Newsletter in your inbox each month.


Sign up here to find us in your inbox every month.

JOIN OUR MAILING LIST
FOLLOW US ON OUR NEW  FACEBOOK PAGE 


900 S Eliseo Dr #103

Greenbrae, CA 94904

(415) 461-1585

Info@NorCalMedicalResearch.com

VISIT OUR WEBSITE
 
Facebook  LinkedIn
X Share This Email
LinkedIn Share This Email